Valuation check: ALEC's profit margin is -680.83%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
Alector (ALEC) currently reports a profit margin of -680.83% as of March 2026. That compares with -139.74% in the prior-year period — down 387.2% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Alector's profit margin history and peer comparisons.
Alector's profit margin decreased from -139.74% to -680.83% — a 387.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Alector's profit margin of -680.83% is lower than the Healthcare sector average of 15.58%. That is roughly 4468.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Alector's current -680.83% should be judged against Healthcare norms (sector average: 15.58%) and against ALEC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -680.83%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Alector, and consider following ALEC for alerts when major investors trade the stock.